Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






White House News First 10 Drugs Chosen For Medicare Price Negotiations Healio

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, White House News First 10 Drugs Chosen For Medicare Price Negotiations Healio is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


White House News First 10 Drugs Chosen For Medicare Price Negotiations Healio | RobinsPost News & Noticias

Orphan drugs exempted from price negotiations to cost Medicare $8.8 billion


The One Big Beautiful Bill Act removed a number of orphan drugs from being subject to price negotiations, and this could cost the Medicare program $8.8 billion over the course of about 10 years.That ... Read More

Trump claimed a win on drug prices, but Big Pharma also scored


President Donald Trump celebrated a long-promised victory Tuesday, announcing that he had used the threat of tariffs to prod pharmaceutical giant Pfizer into cutting U.S. drug prices. But the deal, ... Read More

Trump administration delays effort to address Medicare drug price negotiation loophole


John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — The Trump ... Read More

Trump ‘most favored nation’ drug price negotiations extend past deadline


Negotiations are continuing past President Donald Trump's deadline for companies to implement his "most favored nation" policies. Read More

AstraZeneca makes deal with White House to lower drug prices


The U.K.-based drugmaker became the second to strike a deal with the Trump administration as part of the president's push to rein in U.S. drug prices. Read More

Trump, AstraZeneca announce US drug pricing deal at White House


President Donald Trump unveiled a deal with UK-based drugmaker AstraZeneca on Friday under which the company will sell some medicines at a discount to the government's Medicaid health plan in exchange ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus